US judge dismisses suit alleging Novartis paid kickbacks to promote MS drug Gilenya - Reuters

JHVEPhoto

A U.S. federal judge dismissed a whistleblower lawsuit against Novartis (NYSE:NVS) which alleged that the Swiss pharma giant payed kickbacks to doctors via bogus speaker program to promote multiple sclerosis therapy Gilenya, Reuters reported.

U.S. District Judge Kimba Wood — who had dismissed